![]() |
市場調查報告書
商品編碼
1722611
腦積水分流器市場報告(按類型、產品類型、年齡層、最終用戶和地區)2025 年至 2033 年Hydrocephalus Shunts Market Report by Type, Product Type, Age Group, End User, and Region 2025-2033 |
2024 年全球腦積水分流器市場規模達 4.672 億美元。展望未來, IMARC Group預計到 2033 年市場規模將達到 6.421 億美元,2025-2033 年期間的成長率 (CAGR) 為 3.42%。市場的主要驅動力是腦積水發病率的上升、先進的醫療保健基礎設施以及分流器設計的技術創新。此外,先天性腦積水病例的增加和兒科人口的快速成長也極大地推動了市場的成長。
先天性病例和兒科人口不斷增加
全球腦積水流器市場佔有率的一個顯著趨勢是嬰兒和兒童先天性腦積水的盛行率不斷增加。此外,兒科人口的快速成長也對市場動態起著舉足輕重的作用。根據《世界統計》統計,全球每天有385,000名嬰兒出生,即每年有1.4億名嬰兒出生。先天性病例的增加增加了兒科分流解決方案的需求。根據約翰霍普金斯醫院統計,美國每出生1,000名嬰兒中,就有1至2名患有先天性腦積水。因此,製造商目前正致力於為兒童和嬰兒設計專門的分流器,以滿足該年齡層獨特的生理和解剖需求。
快速採用先進技術
全球腦積水分流器市場正經歷採用先進技術的顯著趨勢,包括防虹吸和可程式分流器。這些創新透過精確調整腦脊髓液流量來改善患者的治療效果。根據《神經外科雜誌》發表的一篇研究文章,在治療腦積水方面,可程式分流器的修復率低於不可程式分流器。因此,可程式分流器被證明更具成本效益。研究表明,7% 的可程式分流器患者需要修復,而 21.6% 的不可編程分流器患者需要修復。此外,遠端監控和遠距醫療系統的結合將進一步推動其應用,改善術後護理並降低頻繁就診的需要。
新興經濟體產品普及率不斷提高
全球腦積水市場佔有率在新興市場呈現正面前景,主要原因是醫療支出增加和醫療基礎設施增強。中國和印度等國家腦積水分流術的採用率正在提高,這主要是因為患者意識的提高和醫療設施的改善。根據產業報告,預計 2024 年亞太地區經濟將強勁成長,其中印度 GDP 預計將成長 5%。政府採取措施加強醫療設施,以及主要公司在這些經濟體中加強影響力,旨在滿足未滿足的醫療需求,進一步推動了市場擴張。
腦室腹膜佔據大部分市場佔有率
腦室腹腔分流術 (VP) 佔據了全球腦積水分流術市場的大部分佔有率,因為它可靠、高效,並且在臨床應用中被廣泛接受。 VP分流術在腦積水患者中表現出很高的成功率,有助於加強其在市場動態中的主導地位。 VP分流器在成人和兒科的廣泛應用進一步促進了其市場的成長。根據臨床報告,全球每年約有 75 萬人被診斷出患有腦積水,而植入 16 萬個 VP 分流器。此外,醫療專業人士的大力支持和有利的醫療政策有助於維持腦積水分流器的市場佔有率和成長。
腦積水瓣膜佔據產業最大佔有率
腦積水瓣膜在調節腦脊髓液流動方面起著關鍵作用。瓣膜是腦積水流動系統的組成部分,因為它們有助於維持顱內壓。可調節壓力閥具有靈活的構造,旨在根據患者需求解決壓力設定問題。固定壓力閥的用途相對較少,但成本低廉且可靠。瓣膜製造技術的進步和創新進一步加強了該領域在全球腦積水分流器市場佔有率的成長。例如,Integra LifeSciences 透過製造各種固定壓力閥(包括 Ultra VS 閥、Pudenz 閥、Mishler 開/關閥和 CODMAN HAKIM 精密固定壓力閥)創新了閥門設計。
兒童是主要的細分市場
由於先天性腦積水盛行率較高以及對早期發現和治療的需求強烈,兒童在全球腦積水分流器市場中佔據最大佔有率。根據美國國立衛生研究院估計,全球每年將新增約 40 萬例兒童腦積水病例。此外,根據《神經外科雜誌》發表的一篇研究文章,亞洲也是兒童腦積水的發生率較高的地區。研究中,亞洲地區非感染後腦積水的確診率為 29%,感染後腦積水的確診率為 10.7%。兒童神經外科的專門分流系統和發展在腦積水分流器市場動態中發揮關鍵作用。此外,對兒童神經退化性疾病的認知不斷增強以及診斷技術的進步促進了該領域的主導地位。
醫院在市場上佔據明顯主導地位
醫院憑藉其優越的醫療基礎設施、執行關鍵手術的能力以及稱職的醫療保健專業人員,在全球腦積水分流器市場預測中佔據最大的最終用戶佔有率。醫院因患者流量增加而獲益匪淺,尤其是需要專門治療的嚴重腦積水病例。根據腦積水協會的數據,每年有超過 4 萬名兒童因腦積水入院,其中近 1 萬名因分流功能障礙入院。此外,全面的術後護理和先進的技術等設施也鞏固了他們在腦積水流量市場中的地位。此外,製造商和醫院之間的策略合作夥伴關係促進了可靠的供應鏈,提高了後者在這一市場佔有率中的關鍵作用。
北美引領市場,佔據腦積水分流器最大市場佔有率
該報告還對所有主要區域市場進行了全面的分析,包括北美(美國和加拿大);歐洲(德國、法國、英國、義大利、西班牙、俄羅斯等);亞太地區(中國、日本、印度、韓國、澳洲、印尼等);拉丁美洲(巴西、墨西哥等);以及中東和非洲。根據報告,北美是腦積水分流器最大的區域市場。
北美是全球腦積水分流器市場佔有率的主導地區,這主要是由於腦積水盛行率的增加和先進的醫療保健基礎設施。根據 USF Health 統計,超過 80 萬美國人患有腦積水,而患有失智症的患者中估計有 1%-5% 患有腦積水。該地區,尤其是美國,在研發領域和先進醫療技術的廣泛應用方面處於領先地位。例如,位於印第安納波利斯的印第安納大學(IU)於2023年獲得美國國立衛生研究院2.43億美元的研究基金。 IU在研發方面發展迅速,並成立了腦積水研究中心,旨在尋找腦積水的解決方案。由於患者意識的提高和該國強力的醫療保健政策,加拿大也對區域市場動態做出了巨大貢獻。優惠的回報政策和根深蒂固的醫療保健提供者網路也加強了這種區域主導地位。
(請注意,這只是關鍵參與者的部分列表,完整列表在報告中提供。)
The global hydrocephalus shunts market size reached USD 467.2 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 642.1 Million by 2033, exhibiting a growth rate (CAGR) of 3.42% during 2025-2033. The market is primarily driven by the rising incidence of hydrocephalus, advanced healthcare infrastructure, and technological innovations in shunts design. Moreover, increasing cases of congenital hydrocephalus and rapid proliferation of pediatric population are significantly driving the market growth.
Increasing Congenital Cases and Pediatric Population
A significant trend in the global hydrocephalus shunts market share is the increasing prevalence of congenital hydrocephalus among infants and children. In addition, rapid growth in pediatric population is also playing a pivotal role in market dynamics. According to The World Counts, each day 385,000 babies are born, i.e., 140 million a year. The heightening incidents of congenital cases has boosted the demand for pediatric shunt solutions. According to John Hopkins Hospital, 1 or 2 of every 1000 infants born in U.S. have congenital hydrocephalus. As a result, manufacturers are currently emphasizing on designing specialized shunts for children and infants, acknowledging the distinct physiological and anatomical needs of this age group.
Rapid Adoption of Advanced Technologies
The global hydrocephalus shunts market is witnessing a notable trend towards the escalating adoption of advanced technologies, including anti-siphon and programmable shunts. Such innovations improve patient outcomes by permitting accurate adjustments of cerebrospinal fluid flow. According to a research article published in the Journal of Neurosurgery, programmable shunts depict lower revision rates than nonprogrammable shunts for the treatment of hydrocephalus. Consequently, programmable shunts are proven to be more cost-efficient. The research showed that 7% of patients with programmable shunts needed revisions, while 21.6% of patients with nonprogrammable shunts required revisions. Additionally, the incorporation of remote monitoring and telehealth systems is further driving adoption by improving post-operative care and lowering the need for frequent hospital visits.
Increasing Product Prevalence in Emerging Economies
The global hydrocephalus market share is witnessing a positive outlook in emerging market principally due to increase in healthcare spending and enhanced healthcare infrastructure. Countries like China and India are undergoing elevated adoption rates of hydrocephalus shunts primarily because of heightening patient awareness and improved medical facilities. As per industry reports, Asia Pacific is projected to depict a robust economic growth in 2024 with India's GDP estimated to grow by 5%. The market expansion is further propelled by government initiatives to enhance healthcare facilities and the strengthening presence of major companies in these economies, targeting to address the unmet medical demands.
Ventriculo-peritoneal accounts for the majority of the market share
The ventriculo-peritoneal (VP) represents the majority of the global hydrocephalus shunts market share as it is reliable, highly effective, and is largely accepted in clinical applications. VP shunts demonstrate high success rates in patients with hydrocephalus, aiding in strengthening its dominance in the market dynamics. The widespread utilization of VP shunts in adults as well as pediatrics further facilitate their market growth. As per a clinical report, approximately 750,000 individuals are diagnosed with hydrocephalus, while 160,000 VP shunts are implanted each year globally. Moreover, the robust support from medical professionals and advantageous healthcare policies assists in sustaining hydrocephalus shunts market share and growth.
Hydrocephalus valves hold the largest share of the industry
Hydrocephalus valves play a critical role in regulating the flow of cerebrospinal fluid. Valves are integral component of hydrocephalus shunt system as they aid in maintaining intracranial pressure. Adjustable pressure valves have flexible built, designed to address pressure settings as per the patient needs. Fixed pressure valves are comparatively less versatile but are cost-efficient and reliable. Advancements in manufacturing technology of valves and innovations further strengthen the segment's growth in the global hydrocephalus shunts market share. For instance, Integra LifeSciences has innovated the valves design by manufacturing various variants of fixed pressure valves, including Ultra VS valves, Pudenz Valves, Mishler On/Off valves, and CODMAN HAKIM Precision Fixed Pressure Valves.
Children represent the leading market segment
Children hold the largest segment in the global hydrocephalus shunts market share due to an elevated prevalence of congenital hydrocephalus and the intense demand for early detection and treatment. According to the National Institutes of Health, it is estimated that each year approximately 400,000 new cases of pediatric hydrocephalus will develop globally. Furthermore, according to a research article published in the Journal of Neurosurgey, Asia also depicts prevalence of pediatric hydrocephalus. In the study, 29% of nonpostinfectious hydrocephalus and 10.7% of postinfectious hydrocephalus were identified across Asia. Specialized shunt systems and development in pediatric neurosurgery for children plays a pivotal role in hydrocephalus shunts market dynamics. Additionally, intensifying awareness about neurogenerative diseases in children and enhanced diagnostics techniques facilitates the segment dominance.
Hospitals exhibit a clear dominance in the market
Hospitals hold the largest segment as an end user in the global hydrocephalus shunts market forecast because of their superior medical infrastructure, ability to execute critical surgeries, and competent healthcare professionals. Hospitals greatly profit from elevated patient inflow, particularly for critical hydrocephalus cases that demand specialized treatments. According to Hydrocephalus Association, pediatric hydrocephalus accounts for over 40,000 hospital admissions annually, with nearly 10,000 of these admissions resulting from shunt malfunctions. Moreover, facilities like thorough post-surgical care and advanced technologies also fortifies their position in the hydrocephalus shunt market dynamics. Additionally, strategic partnerships between manufacturers and hospitals facilitates a reliable supply chain, improving latter's pivotal role in this market share.
North America leads the market, accounting for the largest hydrocephalus shunts market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for hydrocephalus shunts.
North America is the dominant region in the global hydrocephalus shunts market share primarily due to increasing prevalence of hydrocephalus and cutting-edge healthcare infrastructure. According to USF Health, more than 800,000 Americans are suffering with hydrocephalus, while 1%-5% patients that are suffering with dementia are estimated to have hydrocephalus. The region, particularly United States, is leading in research and development sector and extensive utilization of advanced medical technologies. For instance, Indiana University (IU) in Indianapolis was granted with USD 243 million research fund from the National Institutes of Health in 2023. IU is growing rapidly in R&D and has established Hydrocephalus Research Center that aims to discover hydrocephalus solutions. Canada also has a substantial contribution in the regional market dynamics due to rising patient awareness and robust healthcare policies in the country. This regional domination is also strengthened by preferable pay back policies and an entrenched healthcare providers network.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)